Incidental pharmacogenetics findings in an HLA-related research: Considerations for primary prevention.
作者信息
Bakhtiar Mohammed Faizal, Too Chun-Lai, Tang Min-Moon, Sulaiman Salsabil, Tan Lay-Kim, Ahmad-Fauzi Nurul Aain, Kwok Fan-Yin, Murad Shahnaz, Rayyapa Giriyappanavar Chandrashekar
机构信息
Allergy Unit, Allergy & Immunology Research Center, Institute for Medical Research, Ministry of Health Malaysia, Kuala Lumpur, Malaysia.
Immunogenetic Unit, Allergy & Immunology Research Center, Institute for Medical Research, Ministry of Health Malaysia, Kuala Lumpur, Malaysia.
出版信息
Clin Exp Allergy. 2019 Apr;49(4):537-540. doi: 10.1111/cea.13347. Epub 2019 Feb 22.
Abstract
摘要
相似文献
1
Incidental pharmacogenetics findings in an HLA-related research: Considerations for primary prevention.
Clin Exp Allergy. 2019 Apr;49(4):537-540. doi: 10.1111/cea.13347. Epub 2019 Feb 22.
2
Pharmacogenetics of hypersensitivity drug reactions.
Therapie. 2017 Apr;72(2):231-243. doi: 10.1016/j.therap.2016.12.009. Epub 2017 Jan 3.
3
Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
Annu Rev Pharmacol Toxicol. 2012;52:401-31. doi: 10.1146/annurev-pharmtox-010611-134701. Epub 2011 Oct 17.
4
HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.
Pharmacogenomics. 2017 Oct;18(15):1441-1457. doi: 10.2217/pgs-2017-0090. Epub 2017 Oct 11.
5
Immunopharmacogenomics: Mechanisms of HLA-Associated Drug Reactions.
Clin Pharmacol Ther. 2021 Sep;110(3):607-615. doi: 10.1002/cpt.2343. Epub 2021 Jul 17.
6
Human Leukocyte Antigen Associations in Drug Hypersensitivity Reactions.
Clin Lab Med. 2018 Dec;38(4):669-677. doi: 10.1016/j.cll.2018.08.002.
7
Human leukocyte antigens and drug hypersensitivity.
Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):317-23. doi: 10.1097/ACI.0b013e3282370c5f.
8
[Genetic predispositions in drug allergy: the role of HLA].
Rev Med Suisse. 2014 Apr 16;10(426):864-8.
9
HLA and Delayed Drug-Induced Hypersensitivity.
Int Arch Allergy Immunol. 2016;170(3):163-79. doi: 10.1159/000448217. Epub 2016 Aug 26.
10
Pharmacogenetic information derived from analysis of HLA alleles.
Pharmacogenomics. 2008 Feb;9(2):207-14. doi: 10.2217/14622416.9.2.207.
引用本文的文献
1
Pharmacogenetics in Italy: current landscape and future prospects.
Hum Genomics. 2024 Jul 10;18(1):78. doi: 10.1186/s40246-024-00612-w.
本文引用的文献
1
Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population.
Pharmacogenomics J. 2017 Mar;17(2):170-173. doi: 10.1038/tpj.2016.10. Epub 2016 Mar 1.
2
The IGNITE network: a model for genomic medicine implementation and research.
BMC Med Genomics. 2016 Jan 5;9:1. doi: 10.1186/s12920-015-0162-5.
3
Advances in the Pharmacogenomics of Adverse Drug Reactions.
Drug Saf. 2016 Jan;39(1):15-27. doi: 10.1007/s40264-015-0367-8.
4
New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity.
J Allergy Clin Immunol. 2015 Aug;136(2):236-44. doi: 10.1016/j.jaci.2015.06.022.
5
Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.
Asian Pac J Allergy Immunol. 2014 Jun;32(2):111-23.
6
Usability evaluation of pharmacogenomics clinical decision support aids and clinical knowledge resources in a computerized provider order entry system: a mixed methods approach.
Int J Med Inform. 2014 Jul;83(7):473-83. doi: 10.1016/j.ijmedinf.2014.04.008. Epub 2014 May 9.
7
Development and use of active clinical decision support for preemptive pharmacogenomics.
J Am Med Inform Assoc. 2014 Feb;21(e1):e93-9. doi: 10.1136/amiajnl-2013-001993. Epub 2013 Aug 26.
8
Implementing genomic medicine in the clinic: the future is here.
Genet Med. 2013 Apr;15(4):258-67. doi: 10.1038/gim.2012.157. Epub 2013 Jan 10.
Zotero 插件